News search
Research 2 Jul 2025 CNIC researchers have uncovered the evolutionary logic of the OxPhos system—the cell’s “engine”—and developed a tool to detect mutations that cause mitochondrial disease |
Research 5 Jun 2025 This new tool will advance the development of treatments for congenital muscle diseases and cardiomyopathies. |
Research 2 Jun 2025 A team from the CNIC has discovered the key role of conventional type 1 dendritic cells (cDC1) in atherosclerosis and has developed an experimental therapy with immunosuppressive nanoparticles that slows the progression of the disease in animal models. |
Research 29 May 2025 CNIC researchers have discovered that the heart is formed from two independent cell types that act in synchrony from the onset of gastrulation. This finding could help to better understand the origin of certain congenital heart defects and open up new opportunities in regenerative medicine and tissue bioengineering. |
Research 14 Apr 2025 A study led by the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), in collaboration with the Instituto de Investigación Biomédica de Barcelona (IRB Barcelona), has identified the most effective subtype of dendritic cell for generating immune memory in response to cancer |
About the CNIC 3 Apr 2025 Dr. Giuseppe Danilo Norata is a Full Professor of Pharmacology at the Department of Excellence of Pharmacological and Biomolecular Sciences, University of Milan |
Research 2 Apr 2025 Scientists at the CNIC and the University of Bern have found that heart surgery in male mice early in life creates a "memory" passed down to the next generation. Published in Circulation, the study suggests that a parental history of heart surgery should be considered when evaluating cardiovascular health in descendants. |
About the CNIC 26 Mar 2025 Prof. Yasuyuki Fujita, PhD, Kyoto University Graduate School of Medicine, Department of Molecular Oncology |
Research 19 Mar 2025 The discovery, published in Nature, opens the path to new strategies for treating skin diseases and immunological disorders, with special potential for the treatment of inflammation, diabetes, and age-related conditions |
- 1 of 12
- next ›